North Carolina pharmacists' willingness to sell fentanyl test strips: a survey study
- PMID: 36694186
- PMCID: PMC9875410
- DOI: 10.1186/s12954-023-00739-4
North Carolina pharmacists' willingness to sell fentanyl test strips: a survey study
Abstract
Background: Although fentanyl test strips (FTS) can accurately determine the presence of fentanyl in unregulated substances, access to FTS remains limited. This study aimed to examine North Carolina community pharmacists' attitudes and willingness to engage in various behaviors related to FTS sales and distribution.
Methods: A convenience sample of community pharmacists completed an online survey that assessed: (1) comfort initiating an FTS conversation; (2) willingness to sell FTS, distribute FTS instructions, counsel on FTS, refer patients to harm reduction organizations, and advertise FTS; (3) perceived barriers and benefits of selling FTS; and (4) interest in FTS training. Data were collected from March to May 2022. Descriptive statistics were calculated.
Results: Of the 592 pharmacists who participated, most were somewhat or very willing to refer patients to harm reduction organizations for FTS (514, 86.9%), counsel on FTS (485, 81.9%), distribute FTS instructions (475, 80.2%), sell FTS (470, 79.3%), and advertise FTS for sale (372, 62.9%). The most commonly reported benefits of selling FTS were reducing overdose deaths in the community (n = 482, 81.4%) and participating in community harm reduction efforts (n = 455; 76.9%). Barriers commonly reported to selling FTS were: not knowing where to order FTS (n = 295, 49.8%) and discomfort initiating a conversation about FTS (n = 266, 44.9%). Most respondents (88.3%) were interested in FTS training.
Conclusion: North Carolina community pharmacists are willing to engage in various behaviors related to FTS sales and distribution. Most pharmacists were interested in receiving FTS training, which should be created to address pharmacist-reported barriers to FTS sales. Pharmacist distribution of FTS could increase access to FTS at the community level and has the potential to change drug use behavior and reduce overdose deaths.
Keywords: Drug-checking; Fentanyl; Harm reduction; Pharmacist.
© 2023. The Author(s).
Conflict of interest statement
There are no competing interests to disclose.
Figures
Similar articles
-
Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States.Int J Drug Policy. 2019 Jan;63:122-128. doi: 10.1016/j.drugpo.2018.08.007. Epub 2018 Oct 3. Int J Drug Policy. 2019. PMID: 30292493
-
Alabama community pharmacists' knowledge and perceptions regarding fentanyl test strips: A cross-sectional survey.J Am Pharm Assoc (2003). 2024 Jun 22:102148. doi: 10.1016/j.japh.2024.102148. Online ahead of print. J Am Pharm Assoc (2003). 2024. PMID: 38914293
-
The availability of fentanyl test strips in Georgia community pharmacies.J Am Pharm Assoc (2003). 2024 Mar-Apr;64(2):524-529.e1. doi: 10.1016/j.japh.2023.12.015. Epub 2023 Dec 23. J Am Pharm Assoc (2003). 2024. PMID: 38143039
-
Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study.Harm Reduct J. 2019 Jan 8;16(1):3. doi: 10.1186/s12954-018-0276-0. Harm Reduct J. 2019. PMID: 30621699 Free PMC article.
-
Pharmacist roles, training, and perceived barriers in naloxone dispensing: A systematic review.J Am Pharm Assoc (2003). 2020 Jan-Feb;60(1):178-194. doi: 10.1016/j.japh.2019.06.016. Epub 2019 Jul 29. J Am Pharm Assoc (2003). 2020. PMID: 31371179 Review.
Cited by
-
Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chains.J Am Pharm Assoc (2003). 2024 Jan-Feb;64(1):71-78. doi: 10.1016/j.japh.2023.10.014. Epub 2023 Oct 18. J Am Pharm Assoc (2003). 2024. PMID: 37863398
References
-
- U.S. overdose deaths in 2021 increased half as much as in 2020—but are still up 15%. Published May 11, 2022. Accessed May 30, 2022. http://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/202205.htm.
-
- FACT SHEET: White House Releases 2022 National Drug Control Strategy that Outlines Comprehensive Path Forward to Address Addiction and the Overdose Epidemic. The White House. Published April 21, 2022. Accessed May 30, 2022. https://www.whitehouse.gov/briefing-room/statements-releases/2022/04/21/....
-
- Abuse NI on D. Fentanyl DrugFacts. National Institute on Drug Abuse. Published June 1, 2021. Accessed June 16, 2022. https://nida.nih.gov/publications/drugfacts/fentanyl.
-
- NC Office of the Chief Medical Examiner. OCME-Fentanyl-PositiveDeathsApr2022. Published online May 13, 2022. https://injuryfreenc.dph.ncdhhs.gov/DataSurveillance/StatewideOverdoseSu....
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous